299
Views
0
CrossRef citations to date
0
Altmetric
Special Report

A state-of-the-art overview of candidate diagnostic biomarkers for Attention-deficit/hyperactivity disorder (ADHD)

, , , , , , , , & ORCID Icon show all
Pages 259-271 | Received 07 Nov 2023, Accepted 18 Mar 2024, Published online: 26 Mar 2024

References

  • APA. Diagnostic and statistical manual of mental disorders: dSM-5. 5th ed. text revision. Washington (DC): American Psychiatric Association; 2022.
  • Sibley MH, Mitchell JT, Becker SP Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies. Lancet Psychiatry. 2016 Dec;3(12):1157–1165. doi: 10.1016/S2215-0366(16)30190-0
  • Faraone SV, Banaschewski T, Coghill D, et al. The world federation of adhd international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021 Sep;128:789–818. doi: 10.1016/j.neubiorev.2021.01.022
  • Cortese S, Rohde LA ADHD diagnoses: are 116 200 permutations enough? Lancet Child Adolesc Health. 2019 Dec;3(12):844–845. doi: 10.1016/S2352-4642(19)30328-1
  • Willcutt EG, Nigg JT, Pennington BF, et al. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol. 2012 Nov;121(4):991–1010.
  • Hollingdale J, Woodhouse E, Young S, et al. Autistic spectrum disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder: a meta-analytical review. Psychol Med. 2020 Oct;50(13):2240–2253.
  • Mohammadi MR, Zarafshan H, Khaleghi A, et al. Prevalence of ADHD and its comorbidities in a population-based sample. J Atten Disord. 2021 Jun;25(8):1058–1067.
  • Carucci S, Narducci C, Bazzoni M, et al. Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: sex differences. J Neurosci Res. 2023 May;101(5):704–717.
  • Faraone SV, Asherson P, Banaschewski T, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015 Aug 6;1(1):15020. doi: 10.1038/nrdp.2015.20
  • Cortese S, Solmi M, Michelini G, et al. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review. World Psychiatry. 2023 Feb;22(1):129–149. doi: 10.1002/wps.21037
  • Solmi M, Cortese S, Vita G, et al. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders. Mol Psychiatry. 2023 Sep;28(9):3671–3687. doi: 10.1038/s41380-023-02298-3
  • Buitelaar J, Bolte S, Brandeis D, et al. Toward precision medicine in ADHD. Front Behav Neurosci. 2022;16:900981. doi: 10.3389/fnbeh.2022.900981
  • Thome J, Ehlis AC, Fallgatter AJ, et al. Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the world federation of ADHD. World J Biol Psychiatry. 2012 Jul;13(5):379–400.
  • Abi-Dargham A, Horga G The search for imaging biomarkers in psychiatric disorders. Nat Med. 2016 Nov;22(11):1248–1255. doi: 10.1038/nm.4190
  • First M BK CCea. Consensus report of the APA work group on neuroimaging markers of psychiatric disorders. 2012. Available from: https://www.psychiatry.org
  • Faraone SV, Bonvicini C, Scassellati C Biomarkers in the diagnosis of ADHD–promising directions. Curr Psychiatry Rep. 2014 Nov;16(11):497. doi: 10.1007/s11920-014-0497-1
  • Franke B, Faraone SV, Asherson P, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry. 2012 Oct;17(10):960–987.
  • Gizer IR, Ficks C, Waldman ID Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009 Jul;126(1):51–90. doi: 10.1007/s00439-009-0694-x
  • Cheon KA, Ryu YH, Kim JW, et al. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol. 2005 Jan;15(1):95–101.
  • Barnes JJ, Dean AJ, Nandam LS, et al. The molecular genetics of executive function: role of monoamine system genes. Biol Psychiatry. 2011 Jun 15;69(12):e127–e143. doi: 10.1016/j.biopsych.2010.12.040
  • Braet W, Johnson KA, Tobin CT, et al. fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD. Neuropsychologia. 2011 Jun;49(7):1641–1650.
  • Noain D, Avale ME, Wedemeyer C, et al. Identification of brain neurons expressing the dopamine D4 receptor gene using BAC transgenic mice. Eur J Neurosci. 2006 Nov;24(9):2429–2438.
  • Wu J, Xiao H, Sun H, et al. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol Neurobiol. 2012 Jun;45(3):605–620.
  • Kebir O, Joober R. Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci. 2011 Dec;261(8):583–594. doi: 10.1007/s00406-011-0207-5
  • Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19649–19654. doi: 10.1073/pnas.0707741104
  • Wu Z, Yang L, Wang Y. Applying imaging genetics to ADHD: the promises and the challenges. Mol Neurobiol. 2014 Oct;50(2):449–462. doi: 10.1007/s12035-014-8683-z
  • Pan YQ, Qiao L, Xue XD, et al. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: a meta-analysis. Neurosci Lett. 2015 Mar 17;590:101–105. doi: 10.1016/j.neulet.2015.01.076
  • Liu YS, Dai X, Wu W, et al. The association of SNAP25 gene polymorphisms in attention deficit/hyperactivity disorder: a systematic review and meta-analysis. Mol Neurobiol. 2017 Apr;54(3):2189–2200.
  • Grunblatt E, Nemoda Z, Werling AM, et al. The involvement of the canonical wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2019 Sep;180(6):365–376.
  • Kendler KS What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol Psychiatry. 2013 Oct;18(10):1058–1066. doi: 10.1038/mp.2013.50
  • Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019 Jan;51(1):63–75.
  • Hawi Z, Cummins TD, Tong J, et al. The molecular genetic architecture of attention deficit hyperactivity disorder. Mol Psychiatry. 2015 Mar;20(3):289–297.
  • Demontis D, Walters GB, Athanasiadis G, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023 Feb;55(2):198–208. doi: 10.1038/s41588-022-01285-8
  • de Araujo Tavares ME, Cupertino RB, Bandeira CE, et al. Refining patterns of MEF2C effects in white matter microstructure and psychiatric features. J Neural Transm (Vienna). 2023 May;130(5):697–706.
  • Zhernakova DV, Deelen P, Vermaat M, et al. Identification of context-dependent expression quantitative trait loci in whole blood. Nat Genet. 2017 Jan;49(1):139–145.
  • Consortium GT, Deluca DS, Segrè AV. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015 May 8;348(6235):648–660. doi: 10.1126/science.1262110
  • Pujol-Gualdo N, Sanchez-Mora C, Ramos-Quiroga JA, et al. Integrating genomics and transcriptomics: towards deciphering ADHD. Eur Neuropsychopharmacol. 2021 Mar;44:1–13. doi: 10.1016/j.euroneuro.2021.01.002
  • Fahira A, Li Z, Liu N, et al. Prediction of causal genes and gene expression analysis of attention-deficit hyperactivity disorder in the different brain region, a comprehensive integrative analysis of ADHD. Behav Brain Res. 2019 May 17;364:183–192. doi: 10.1016/j.bbr.2019.02.010
  • Brikell I, Larsson H, Lu Y, et al. The contribution of common genetic risk variants for ADHD to a general factor of childhood psychopathology. Mol Psychiatry. 2020 Aug;25(8):1809–1821.
  • Sato JR, Biazoli CE, Bueno APA, et al. Polygenic risk score for attention-deficit/hyperactivity disorder and brain functional networks segregation in a community-based sample. Genes Brain Behav. 2023 Apr;22(2):e12838.
  • Lee PH, Anttila V, Won H, et al. Electronic address pmhe, cross-disorder group of the psychiatric genomics c. genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019 Dec 12;179(7):1469–1482 e11. doi: 10.1016/j.cell.2019.11.020
  • Li JJ, He Q Polygenic scores for ADHD: a meta-analysis. Res Child Adolesc Psychopathol. 2021 Mar;49(3):297–310. doi: 10.1007/s10802-021-00774-4
  • Cecil CAM, Nigg JT. Epigenetics and ADHD: reflections on Current knowledge, research priorities and translational potential. Mol diagn ther. Mol Diagn Ther. 2022 Nov;26(6):581–606. doi: 10.1007/s40291-022-00609-y
  • Mooney MA, Ryabinin P, Wilmot B, et al. Large epigenome-wide association study of childhood ADHD identifies peripheral DNA methylation associated with disease and polygenic risk burden. Transl Psychiatry. 2020 Jan 21;10(1):8. doi: 10.1038/s41398-020-0710-4
  • Joubert BR, Felix JF, Yousefi P, et al. DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis. Am J Hum Genet. 2016 Apr 7;98(4):680–696. doi: 10.1016/j.ajhg.2016.02.019
  • Peter CJ, Fischer LK, Kundakovic M, et al. DNA methylation signatures of early childhood malnutrition associated with impairments in attention and cognition. Biol Psychiatry. 2016 Nov 15;80(10):765–774. doi: 10.1016/j.biopsych.2016.03.2100
  • Miyake K, Miyashita C, Ikeda-Araki A, et al. DNA methylation of GFI1 as a mediator of the association between prenatal smoking exposure and ADHD symptoms at 6 years: the hokkaido study on environment and children’s health. Clin Epigenetics. 2021 Apr 7;13(1):74. doi: 10.1186/s13148-021-01063-z
  • Choi YJ, Cho J, Hong YC, et al. DNA methylation is associated with prenatal exposure to sulfur dioxide and childhood attention-deficit hyperactivity disorder symptoms. Sci Rep. 2023 Mar 1;13(1):3501. doi: 10.1038/s41598-023-29843-y
  • Horvath S, Oshima J, Martin GM, et al. Epigenetic clock for skin and blood cells applied to hutchinson gilford progeria syndrome and ex vivo studies. Aging (Albany NY). 2018 Jul 26;10(7):1758–1775. doi: 10.18632/aging.101508
  • Carvalho G, Costa T, Nascimento AM, et al. DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients. Clin Neurol Neurosur. 2023 May;228:107714. doi: 10.1016/j.clineuro.2023.107714
  • Arpawong TE, Klopack ET, Kim JK, et al. ADHD genetic burden associates with older epigenetic age: mediating roles of education, behavioral and sociodemographic factors among older adults. Clin Epigenetics. 2023 Apr 26;15(1):67. doi: 10.1186/s13148-023-01484-y
  • Peedicayil J. The role of epigenetics in the pathogenesis and potential treatment of attention deficit hyperactivity disorder. Curr Neuropharmacol. 2022 Aug 3;20(9):1642–1650. doi: 10.2174/1570159X19666210920091036
  • Güler Aksu GD P. Evaluation of the Indicators of Inflammation in Children and Adolescents with Attention Deficit and Hyperactivity Disorder: Effect of Sex and Subtype. Duzce Med J. 2020;22(2):84–90. doi: 10.18678/dtfd.690128
  • Ceylan M, Sener S, Bayraktar AC, et al. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1491–1494. doi: 10.1016/j.pnpbp.2010.08.010
  • Bulut M, Selek S, Gergerlioglu HS, et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci. 2007 Nov;32(6):435–438.
  • Selek S, Savas HA, Gergerlioglu HS, et al. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol. 2008 Oct;79(2):256–259.
  • Brookes KJ, Chen W, Xu X, et al. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006 Nov 15;60(10):1053–1061. doi: 10.1016/j.biopsych.2006.04.025
  • Nayak S, Sahu S, Patra S, et al. Assessment of copper and zinc levels in hair and urine of children with attention deficit hyperactivity disorder: a case-control study in Eastern India. Cureus. 2021 Dec;13(12):e20692.
  • Wirsching J, Grassmann S, Eichelmann F, et al. Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS). BMC Med Res Methodol. 2018 Nov 6;18(1):122. doi: 10.1186/s12874-018-0583-x
  • Chang JP, Su KP, Mondelli V, et al. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. 2018 Feb;43(3):534–545. doi: 10.1038/npp.2017.160
  • Chang JP, Su KP, Mondelli V, et al. Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis. Transl Psychiatry. 2021 Aug 19;11(1):430. doi: 10.1038/s41398-021-01550-0
  • Wang LJ, Yang CY, Chou WJ, et al. Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2020 Mar;29(3):287–297.
  • Wang LJ, Li SC, Yeh YM, et al. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder. J Child Psychol Psychiatr. 2023 Sep;64(9):1280–1291.
  • Payen A, Chen MJ, Carter TG, et al. Childhood ADHD, going beyond the brain: a meta-analysis on peripheral physiological markers of the heart and the gut. Front Endocrinol. 2022;13:738065. doi: 10.3389/fendo.2022.738065
  • Bansal R, Staib LH, Laine AF, et al. Anatomical brain images alone can accurately diagnose chronic neuropsychiatric illnesses. PLoS One. 2012;7(12):e50698. doi: 10.1371/journal.pone.0050698
  • Hart H, Chantiluke K, Cubillo AI, et al. Pattern classification of response inhibition in ADHD: toward the development of neurobiological markers for ADHD. Hum Brain Mapp. 2014 Jul;35(7):3083–3094.
  • Hart H, Marquand AF, Smith A, et al. Predictive neurofunctional markers of attention-deficit/hyperactivity disorder based on pattern classification of temporal processing. J Am Acad Child Adolesc Psychiatry. 2014 May;53(5):569–578 e1.
  • Yoncheva YN, Somandepalli K, Reiss PT, et al. Mode of anisotropy reveals global diffusion alterations in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2016 Feb;55(2):137–145.
  • Anderson A, Douglas PK, Kerr WT, et al. Non-negative matrix factorization of multimodal MRI, fMRI and phenotypic data reveals differential changes in default mode subnetworks in ADHD. Neuroimage. 2014 Nov 15;102 Pt 1:207–219. doi: 10.1016/j.neuroimage.2013.12.015
  • SS HBS, Sarhan M, Samir S, et al. T2 magnetic resonance imaging: a non-invasive biomarker of brain iron content in children with attention-deficit/hyperactivity disorder. Egypt J Radiol Nucl Med. 2017;48(1):161–167. doi: 10.1016/j.ejrnm.2016.08.001
  • Sutoko S, Monden Y, Tokuda T, et al. Exploring attentive task-based connectivity for screening attention deficit/hyperactivity disorder children: a functional near-infrared spectroscopy study. Neurophotonics. 2019 Oct;6(4):045013.
  • Yasumura A, Omori M, Fukuda A, et al. Applied machine learning method to predict children with ADHD using prefrontal cortex activity: a multicenter study in Japan. J Atten Disord. 2020 Dec;24(14):2012–2020.
  • Yoo JH, Kim JI, Kim BN, et al. Exploring characteristic features of attention-deficit/hyperactivity disorder: findings from multi-modal MRI and candidate genetic data. Brain Imaging Behav. 2020 Dec;14(6):2132–2147.
  • Chaim-Avancini TM, Doshi J, Zanetti MV, et al. Neurobiological support to the diagnosis of ADHD in stimulant-naive adults: pattern recognition analyses of MRI data. Acta Psychiatr Scand. 2017 Dec;136(6):623–636.
  • Luo Y, Alvarez TL, Halperin JM, et al. Multimodal neuroimaging-based prediction of adult outcomes in childhood-onset ADHD using ensemble learning techniques. NeuroImage Clin. 2020;26:102238. doi: 10.1016/j.nicl.2020.102238
  • Shang CY, Sheng C, Yang LK, et al. Differential brain activations in adult attention-deficit/hyperactivity disorder subtypes: a counting Stroop functional MRI study. Brain Imaging Behav. 2018 Jun;12(3):882–890.
  • Sun H, Chen Y, Huang Q, et al. Psychoradiologic utility of MR imaging for diagnosis of attention deficit hyperactivity disorder: a radiomics analysis. Radiology. 2018 May;287(2):620–630.
  • Lin HY, Kessler D, Tseng WI, et al. Increased functional segregation related to the salience network in unaffected siblings of youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2021 Jan;60(1):152–165.
  • Chiang HL, Hsu YC, Shang CY, et al. White matter endophenotype candidates for ADHD: a diffusion imaging tractography study with sibling design. Psychol Med. 2020 May;50(7):1203–1213.
  • Espinet SD, Anderson JE, Zelazo PD. N2 amplitude as a neural marker of executive function in young children: an ERP study of children who switch versus perseverate on the dimensional change card sort. Dev Cogn Neurosci. 2012 Feb 15;2 Suppl 1(Suppl 1):S49–S58. doi: 10.1016/j.dcn.2011.12.002
  • Teodoro T, Koreki A, Meppelink AM, et al. Contingent negative variation: a biomarker of abnormal attention in functional movement disorders. Eur J Neurol. 2020 Jun;27(6):985–994.
  • Fitzgerald K, Todd J. Making sense of mismatch negativity. Front Psychiatry. 2020;11:468. doi: 10.3389/fpsyt.2020.00468
  • Buzsaki G, Schomburg EW What does gamma coherence tell us about inter-regional neural communication? Nat Neurosci. 2015 Apr;18(4):484–489. doi: 10.1038/nn.3952
  • Griffiths KR, Jurigova BG, Leikauf JE, et al. A signature of attention-elicited electrocortical activity distinguishes response from non-response to the non-stimulant atomoxetine in children and adolescents with ADHD. J Atten Disord. 2019 May;23(7):744–753.
  • Albrecht B, Brandeis D, Uebel H, et al. Action monitoring in boys with attention-deficit/hyperactivity disorder, their nonaffected siblings, and normal control subjects: evidence for an endophenotype. Biol Psychiatry. 2008 Oct 1;64(7):615–625. doi: 10.1016/j.biopsych.2007.12.016
  • Yamamuro K, Ota T, Iida J, et al. Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder. Neuropsychiatr Dis Treat. 2016;12:3183–3190. doi: 10.2147/NDT.S120540
  • Kim S, Baek JH, Kwon YJ, et al. Machine-learning-based diagnosis of drug-naive adult patients with attention-deficit hyperactivity disorder using mismatch negativity. Transl Psychiatry. 2021 Sep 18;11(1):484. doi: 10.1038/s41398-021-01604-3
  • Munger M, Candrian G, Kasper J, et al. Behavioral and neurophysiological markers of ADHD in children, adolescents, and adults: a large-scale clinical study. Clin EEG Neurosci. 2021 Sep;52(5):311–320.
  • Chu KC, Lu HK, Huang MC, et al. Using mobile electroencephalography and actigraphy to diagnose attention-deficit/hyperactivity disorder: case-control comparison study. JMIR Ment Health. 2020 Jun 19;7(6):e12158. doi: 10.2196/12158
  • Li F, Zheng Y, Smith SD, et al. A preliminary study of movement intensity during a Go/No-go task and its association with ADHD outcomes and symptom severity. Child Adolesc Psychiatr Ment Health. 2016;10(1):47. doi: 10.1186/s13034-016-0135-2
  • Bellato A, Arora I, Hollis C, et al. Is autonomic nervous system function atypical in attention deficit hyperactivity disorder (ADHD)? A systematic review of the evidence. Neurosci Biobehav Rev. 2020 Jan;108:182–206. doi: 10.1016/j.neubiorev.2019.11.001
  • Idrees I, Bellato A, Cortese S, et al. The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2023 Jan;144:104968. doi: 10.1016/j.neubiorev.2022.104968
  • Cheng YC, Huang YC, Huang WL. Heart rate variability in individuals with autism spectrum disorders: a meta-analysis. Neurosci Biobehav Rev. 2020 Nov;118:463–471. doi: 10.1016/j.neubiorev.2020.08.007
  • Tarle SJ, Alderson RM, Patros CHG, et al. Attention-deficit/hyperactivity disorder and phonological working memory: methodological variability affects clinical and experimental performance metrics. Neuropsychology. 2017 May;31(4):383–394.
  • van Ewijk H, Heslenfeld DJ, Luman M, et al. Visuospatial working memory in ADHD patients, unaffected siblings, and healthy controls. J Atten Disord. 2014 May;18(4):369–378.
  • Riccioni A, Radua J, Ashaye FO, et al. Systematic review and meta-analysis: reporting and representation of race/ethnicity in 310 randomized controlled trials of attention-deficit/hyperactivity disorder medications. J Am Acad Child Adolesc Psychiatry. 2023 Oct 25. doi: 10.1016/j.jaac.2023.09.544
  • Karalunas SL, Nigg JT. Heterogeneity and subtyping in attention-deficit/hyperactivity disorder-considerations for emerging research using person-centered computational approaches. Biol Psychiatry. 2020 Jul 1;88(1):103–110. doi: 10.1016/j.biopsych.2019.11.002
  • Dwyer P, Wang X, De Meo-Monteil R, et al. Defining clusters of young autistic and typically developing children based on loudness-dependent auditory electrophysiological responses. Mol Autism. 2020 Jun 15;11(1):48. doi: 10.1186/s13229-020-00352-3
  • Juarez-Martinez EL, Sprengers JJ, Cristian G, et al. Prediction of behavioral improvement through resting-state electroencephalography and clinical severity in a randomized controlled trial testing bumetanide in autism spectrum disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Mar;8(3):251–261.
  • Voetterl H, van Wingen G, Michelini G, et al. Brainmarker-I differentially predicts remission to various attention-deficit/hyperactivity disorder treatments: a discovery, transfer, and blinded validation study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Jan;8(1):52–60.
  • Bellato A, Hall CL, Groom MJ, et al. Practitioner review: clinical utility of the QbTest for the assessment and diagnosis of attention-deficit/hyperactivity disorder - a systematic review and meta-analysis. J Child Psychol Psychiatr. 2023 Oct 6. doi: 10.1111/jcpp.13901
  • Pievsky MA, McGrath RE. The neurocognitive profile of attention-deficit/hyperactivity disorder: a review of meta-analyses. Arch Clin Neuropsychol. 2018 Mar 1;33(2):143–157. doi: 10.1093/arclin/acx055
  • Nigg JT, Willcutt EG, Doyle AE, et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005 Jun 1;57(11):1224–1230. doi: 10.1016/j.biopsych.2004.08.025
  • Sonuga-Barke E, Bitsakou P, Thompson M. Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Apr;49(4):345–355. doi: 10.1097/00004583-201004000-00009
  • Nigg JT, Casey BJ. An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol. 2005 Summer;17(3):785–806. doi: 10.1017/S0954579405050376
  • Purper-Ouakil D, Ramoz N, Lepagnol-Bestel AM, et al. Neurobiology of attention deficit/hyperactivity disorder. Pediatr Res. 2011 May;69(5 Pt 2):69R–76R.
  • Parlatini V, Radua J, Solanes Font A, et al. Poor response to methylphenidate is associated with a smaller dorsal attentive network in adult attention-deficit/hyperactivity disorder (ADHD). Transl Psychiatry. 2023 Sep 30;13(1):303. doi: 10.1038/s41398-023-02598-w
  • Michelini G, Norman LJ, Shaw P, et al. Treatment biomarkers for ADHD: taking stock and moving forward. Transl Psychiatry. 2022 Oct 12;12(1):444. doi: 10.1038/s41398-022-02207-2
  • Loth E, Ahmad J, Chatham C, et al. The meaning of significant mean group differences for biomarker discovery. PLoS Comput Biol. 2021 Nov;17(11):e1009477.
  • Boksa P A way forward for research on biomarkers for psychiatric disorders. J Psychiatry Neurosci. 2013 Mar;38(2):75–77. doi: 10.1503/jpn.130018
  • Parlatini V, Itahashi T, Lee Y, et al. White matter alterations in attention-deficit/hyperactivity disorder (ADHD): a systematic review of 129 diffusion imaging studies with meta-analysis. Mol Psychiatry. 2023 Oct;28(10):4098–4123. doi: 10.1038/s41380-023-02173-1
  • Nakao T, Radua J, Rubia K, et al. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry. 2011 Nov;168(11):1154–163.
  • Huys QJ, Maia TV, Frank MJ Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci. 2016 Mar;19(3):404–413. doi: 10.1038/nn.4238
  • Orru G, Pettersson-Yeo W, Marquand AF, et al. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. 2012 Apr;36(4):1140–1152.
  • Wolfers T, Buitelaar JK, Beckmann CF, et al. From estimating activation locality to predicting disorder: a review of pattern recognition for neuroimaging-based psychiatric diagnostics. Neurosci Biobehav Rev. 2015 Oct;57:328–349. doi: 10.1016/j.neubiorev.2015.08.001
  • Loth E, Spooren W, Ham LM, et al. Identification and validation of biomarkers for autism spectrum disorders. Nat Rev Drug Discov. 2016 Jan;15(1):70–73.doi: 10.1038/nrd.2015.7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.